{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:11:44Z","timestamp":1794276704164,"version":"4.9.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"crossref","award":["2013-14272"],"award-info":[{"award-number":["2013-14272"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Italian Ministry of Health","award":["CCM project, approved by D.M. 05\/03\/2012"],"award-info":[{"award-number":["CCM project, approved by D.M. 05\/03\/2012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12916-015-0545-7","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T15:47:28Z","timestamp":1451922448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":468,"title":["Cancer and fertility preservation: international recommendations from an expert meeting"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-5296","authenticated-orcid":false,"given":"Matteo","family":"Lambertini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Pescio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Y.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Hatem A.","family":"Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedro A.","family":"Peccatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Revelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Salvagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo M.","family":"Ubaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"La Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristofaro","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Hamish","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Anserini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,4]]},"reference":[{"key":"545_CR1","volume-title":"Cancer Facts & Figures 2015","author":"American Cancer Society","year":"2015","unstructured":"American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015."},{"issue":"1","key":"545_CR2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1701-2163(16)35138-6","volume":"34","author":"J-A Johnson","year":"2012","unstructured":"Johnson J-A, Tough S. Society of Obstetricians and Gynaecologists of Canada, Delayed child-bearing. J Obstet Gynaecol Can. 2012;34(1):80\u201393.","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"545_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.soncn.2009.08.004","volume":"25","author":"A Rosen","year":"2009","unstructured":"Rosen A, Rodriguez-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs. 2009;25(4):268\u201377.","journal-title":"Semin Oncol Nurs"},{"issue":"2","key":"545_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/pon.1875","volume":"21","author":"AL Canada","year":"2012","unstructured":"Canada AL, Schover LR. The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology. 2012;21(2):134\u201343.","journal-title":"Psychooncology"},{"issue":"2","key":"545_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11764-011-0211-9","volume":"6","author":"JR Gorman","year":"2012","unstructured":"Gorman JR, Bailey S, Pierce JP, Su HI. How do you feel about fertility and parenthood? The voices of young female cancer survivors. J Cancer Surviv Res Pract. 2012;6(2):200\u20139.","journal-title":"J Cancer Surviv Res Pract"},{"issue":"20","key":"545_CR6","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1200\/JCO.2004.01.159","volume":"22","author":"AH Partridge","year":"2004","unstructured":"Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22(20):4174\u201383.","journal-title":"J Clin Oncol"},{"issue":"11","key":"545_CR7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1200\/JCO.2013.52.8877","volume":"32","author":"KJ Ruddy","year":"2014","unstructured":"Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014;32(11):1151\u20136.","journal-title":"J Clin Oncol"},{"issue":"2","key":"545_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/pon.3384","volume":"23","author":"E Senkus","year":"2014","unstructured":"Senkus E, Gomez H, Dirix L, Jerusalem G, Murray E, Van Tienhoven G, et al. Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3\u201398. Psychooncology. 2014;23(2):173\u201382.","journal-title":"Psychooncology"},{"issue":"18","key":"545_CR9","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","volume":"24","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917\u201331.","journal-title":"J Clin Oncol"},{"issue":"19","key":"545_CR10","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","volume":"31","author":"AW Loren","year":"2013","unstructured":"Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2013;31(19):2500\u201310.","journal-title":"J Clin Oncol"},{"issue":"Suppl 6","key":"545_CR11","doi-asserted-by":"publisher","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","volume":"24","author":"FA Peccatori","year":"2013","unstructured":"Peccatori FA, Azim Jr HA, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi160\u201370.","journal-title":"Ann Oncol"},{"issue":"8","key":"545_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, Appleby P, Barnes I, Reeves G. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94(8):606\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"545_CR13","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/jnci\/djj376","volume":"98","author":"AH Eliassen","year":"2006","unstructured":"Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006;98(19):1406\u201315.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"545_CR14","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/bcr3394","volume":"15","author":"RT Fortner","year":"2013","unstructured":"Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses\u2019 Health Study II. Breast Cancer Res. 2013;15(2):R19.","journal-title":"Breast Cancer Res"},{"key":"545_CR15","unstructured":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1997;350(9084):1047\u201359."},{"issue":"3","key":"545_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/aje\/kwn318","volume":"169","author":"R Calderon-Margalit","year":"2009","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R, Kleinhaus K, Perrin MC, Manor O, et al. Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol. 2009;169(3):365\u201375.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"545_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/humrep\/deq307","volume":"26","author":"B K\u00e4ll\u00e9n","year":"2011","unstructured":"K\u00e4ll\u00e9n B, Finnstr\u00f6m O, Lindam A, Nilsson E, Nygren K-G, Olausson PO. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod. 2011;26(1):253\u20138.","journal-title":"Hum Reprod"},{"issue":"2","key":"545_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10549-015-3328-0","volume":"150","author":"A Gennari","year":"2015","unstructured":"Gennari A, Costa M, Puntoni M, Paleari L, De Censi A, Sormani MP, et al. Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies. Breast Cancer Res Treat. 2015;150(2):405\u201313.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"545_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1158\/1055-9965.EPI-13-0996","volume":"23","author":"LA Brinton","year":"2014","unstructured":"Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Ruggieri D, et al. Long-term relationship of ovulation-stimulating drugs to breast cancer risk. Cancer Epidemiol Biomark Prev. 2014;23(4):584\u201393.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"545_CR20","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/cncr.26459","volume":"118","author":"JM Letourneau","year":"2012","unstructured":"Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118(6):1710\u20137.","journal-title":"Cancer"},{"issue":"5","key":"545_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/ijc.26045","volume":"129","author":"H Stensheim","year":"2011","unstructured":"Stensheim H, Cvancarova M, M\u00f8ller B, Foss\u00e5 SD. Pregnancy after adolescent and adult cancer: a population-based matched cohort study. Int J Cancer J Int Cancer. 2011;129(5):1225\u201336.","journal-title":"Int J Cancer J Int Cancer"},{"issue":"1","key":"545_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejca.2010.09.007","volume":"47","author":"HA Azim Jr","year":"2011","unstructured":"Azim Jr HA, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011;47(1):74\u201383.","journal-title":"Eur J Cancer"},{"issue":"1","key":"545_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1200\/JCO.2012.44.2285","volume":"31","author":"HA Azim Jr","year":"2013","unstructured":"Azim Jr HA, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol. 2013;31(1):73\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"545_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A","volume":"65","author":"R Sutton","year":"1990","unstructured":"Sutton R, Buzdar AU, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer. 1990;65(4):847\u201350.","journal-title":"Cancer"},{"issue":"9","key":"545_CR25","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1371\/journal.pmed.0030336","volume":"3","author":"K Dalberg","year":"2006","unstructured":"Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer--a population-based cohort study from Sweden. PLoS Med. 2006;3(9):e336.","journal-title":"PLoS Med"},{"issue":"1","key":"545_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/sj.bjc.6602878","volume":"94","author":"V Langagergaard","year":"2006","unstructured":"Langagergaard V, Gislum M, Skriver MV, N\u00f8rg\u00e5rd B, Lash TL, Rothman KJ, et al. Birth outcome in women with breast cancer. Br J Cancer. 2006;94(1):142\u20136.","journal-title":"Br J Cancer"},{"issue":"1","key":"545_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-012-1996-6","volume":"133","author":"HA Azim","year":"2012","unstructured":"Azim HA, Metzger-Filho O, de Azambuja E, Loibl S, Focant F, Gresko E, et al. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01\u201301). Breast Cancer Res Treat. 2012;133(1):387\u201391.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"545_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ijrobp.2011.12.066","volume":"84","author":"V Sanctis De","year":"2012","unstructured":"De Sanctis V, Filippone FR, Alf\u00f2 M, Muni R, Cavalieri E, Pulsoni A, et al. Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012;84(3):755\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"545_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1200\/JCO.2011.35.0504","volume":"30","author":"JF Winther","year":"2012","unstructured":"Winther JF, Olsen JH, Wu H, Shyr Y, Mulvihill JJ, Stovall M, et al. Genetic disease in the children of Danish survivors of childhood and adolescent cancer. J Clin Oncol. 2012;30(1):27\u201333.","journal-title":"J Clin Oncol"},{"issue":"7586","key":"545_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/bmj.39035.667176.55","volume":"334","author":"A Ives","year":"2007","unstructured":"Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007;334(7586):194.","journal-title":"BMJ"},{"issue":"3","key":"545_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000336830","volume":"35","author":"B Lawrenz","year":"2012","unstructured":"Lawrenz B, Henes M, Neunhoeffer E, Fehm T, Huebner S, Kanz L, et al. Pregnancy after successful cancer treatment: what needs to be considered? Onkologie. 2012;35(3):128\u201332.","journal-title":"Onkologie"},{"key":"545_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/jncimonographs\/lgi022","volume":"34","author":"HOD Critchley","year":"2005","unstructured":"Critchley HOD, Wallace WHB. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr. 2005;34:64\u20138.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"545_CR33","doi-asserted-by":"publisher","first-page":"f1190","DOI":"10.1136\/bmj.f1190","volume":"346","author":"WHB Wallace","year":"2013","unstructured":"Wallace WHB, Thompson L, Anderson RA. Guideline Development Group, Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance. BMJ. 2013;346:f1190.","journal-title":"BMJ"},{"issue":"3","key":"545_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.breast.2015.01.005","volume":"24","author":"O Pagani","year":"2015","unstructured":"Pagani O, Ruggeri M, Manunta S, Saunders C, Peccatori F, Cardoso F, et al. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? Breast. 2015;24(3):201\u20137.","journal-title":"Breast"},{"issue":"1","key":"545_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/humrep\/deg016","volume":"18","author":"WHB Wallace","year":"2003","unstructured":"Wallace WHB, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18(1):117\u201321.","journal-title":"Hum Reprod"},{"issue":"3","key":"545_CR36","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","volume":"62","author":"WHB Wallace","year":"2005","unstructured":"Wallace WHB, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"185","key":"545_CR37","doi-asserted-by":"publisher","first-page":"185ra62","DOI":"10.1126\/scitranslmed.3005402","volume":"5","author":"L Kalich-Philosoph","year":"2013","unstructured":"Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and \u201cburnout\u201d; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra62.","journal-title":"Sci Transl Med"},{"issue":"7","key":"545_CR38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S2213-8587(15)00039-X","volume":"3","author":"RA Anderson","year":"2015","unstructured":"Anderson RA, Mitchell RT, Kelsey TW, Spears N, Telfer EE, Wallace WHB. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol. 2015;3(7):556\u201367.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"545_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","volume":"6","author":"WHB Wallace","year":"2005","unstructured":"Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6(4):209\u201318.","journal-title":"Lancet Oncol"},{"issue":"10","key":"545_CR40","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1470-2045(14)70334-1","volume":"15","author":"WHB Wallace","year":"2014","unstructured":"Wallace WHB, Smith AG, Kelsey TW, Edgar AE, Anderson RA. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014;15(10):1129\u201336.","journal-title":"Lancet Oncol"},{"issue":"1","key":"545_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.fertnstert.2011.10.005","volume":"97","author":"ME Abusief","year":"2012","unstructured":"Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Fertil Steril. 2012;97(1):154\u20139.","journal-title":"Fertil Steril"},{"issue":"5","key":"545_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/CCO.0000000000000105","volume":"26","author":"S Lavery","year":"2014","unstructured":"Lavery S, Tsiligiannis S, Carby A. Reproductive options for female cancer patients: balancing hope and realistic expectation. Curr Opin Oncol. 2014;26(5):501\u20137.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"545_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1200\/JCO.2011.37.1989","volume":"30","author":"MAE Kaaij Van der","year":"2012","unstructured":"Van der Kaaij MAE, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, et al. Premature ovarian failure and fertility in long-term survivors of Hodgkin\u2019s lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d\u2019Etude des Lymphomes de l\u2019Adulte Cohort Study. J Clin Oncol. 2012;30(3):291\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"545_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","volume":"31","author":"K Behringer","year":"2013","unstructured":"Behringer K, Mueller H, Goergen H, Thielen I, Eibl AD, Stumpf V, et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31(2):231\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"545_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756287210368279","volume":"2","author":"DH Williams","year":"2010","unstructured":"Williams DH. Sperm banking and the cancer patient. Ther Adv Urol. 2010;2(1):19\u201334.","journal-title":"Ther Adv Urol"},{"issue":"3","key":"545_CR46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00404-010-1772-y","volume":"283","author":"B Lawrenz","year":"2011","unstructured":"Lawrenz B, Jauckus J, Kupka MS, Strowitzki T, von Wolff M. Fertility preservation in >1,000 patients: patient\u2019s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet. 2011;283(3):651\u20136.","journal-title":"Arch Gynecol Obstet"},{"issue":"17","key":"545_CR47","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1200\/JCO.2011.40.6470","volume":"30","author":"GM Armuand","year":"2012","unstructured":"Armuand GM, Rodriguez-Wallberg KA, Wettergren L, Ahlgren J, Enblad G, H\u00f6glund M, et al. Sex differences in fertility-related information received by young adult cancer survivors. J Clin Oncol. 2012;30(17):2147\u201353.","journal-title":"J Clin Oncol"},{"issue":"4","key":"545_CR48","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1200\/JCO.2005.01.134","volume":"23","author":"CM Duffy","year":"2005","unstructured":"Duffy CM, Allen SM, Clark MA. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol. 2005;23(4):766\u201373.","journal-title":"J Clin Oncol"},{"issue":"3","key":"545_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/07347332.2011.563344","volume":"29","author":"C Hohmann","year":"2011","unstructured":"Hohmann C, Borgmann-Staudt A, Rendtorff R, Reinmuth S, Holzhausen S, Willich SN, et al. Patient counselling on the risk of infertility and its impact on childhood cancer survivors: results from a national survey. J Psychosoc Oncol. 2011;29(3):274\u201385.","journal-title":"J Psychosoc Oncol"},{"issue":"2","key":"545_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11764-007-0019-9","volume":"1","author":"GP Quinn","year":"2007","unstructured":"Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, et al. Discussion of fertility preservation with newly diagnosed patients: oncologists\u2019 views. J Cancer Surviv Res Pract. 2007;1(2):146\u201355.","journal-title":"J Cancer Surviv Res Pract"},{"issue":"3","key":"545_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10815-010-9504-6","volume":"28","author":"TS K\u00f6hler","year":"2011","unstructured":"K\u00f6hler TS, Kondapalli LA, Shah A, Chan S, Woodruff TK, Brannigan RE. Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet. 2011;28(3):269\u201377.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"545_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1442-2042.2010.02484.x","volume":"17","author":"GR Dohle","year":"2010","unstructured":"Dohle GR. Male infertility in cancer patients: Review of the literature. Int J Urol. 2010;17(4):327\u201331.","journal-title":"Int J Urol"},{"issue":"Suppl 1","key":"545_CR53","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.ejogrb.2003.11.024","volume":"113","author":"K Chung","year":"2004","unstructured":"Chung K, Irani J, Knee G, Efymow B, Blasco L, Patrizio P. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur J Obstet Gynecol Reprod Biol. 2004;113 Suppl 1:S7\u2013S11.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"545_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jncimonographs\/lgi005","volume":"34","author":"A Agarwal","year":"2005","unstructured":"Agarwal A, Allamaneni SSR. Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr. 2005;34:9\u201312.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"21","key":"545_CR55","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/jnci\/dji339","volume":"97","author":"M Bryd\u00f8y","year":"2005","unstructured":"Bryd\u00f8y M, Foss\u00e5 SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst. 2005;97(21):1580\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"545_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1200\/JCO.2011.37.2938","volume":"30","author":"LB Signorello","year":"2012","unstructured":"Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE, et al. Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol. 2012;30(3):239\u201345.","journal-title":"J Clin Oncol"},{"issue":"5","key":"545_CR57","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jnci\/djq550","volume":"103","author":"O St\u00e5hl","year":"2011","unstructured":"St\u00e5hl O, Boyd HA, Giwercman A, Lindholm M, Jensen A, Kj\u00e6r SK, et al. Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. J Natl Cancer Inst. 2011;103(5):398\u2013406.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"545_CR58","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11764-014-0398-7","volume":"9","author":"A Garc\u00eda","year":"2015","unstructured":"Garc\u00eda A, Herrero MB, Holzer H, Tulandi T, Chan P. Assisted reproductive outcomes of male cancer survivors. J Cancer Surviv Res Pract. 2015;9(2):208\u201314.","journal-title":"J Cancer Surviv Res Pract"},{"issue":"1","key":"545_CR59","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/1008-682X.122194","volume":"16","author":"P Ping","year":"2014","unstructured":"Ping P, Gu B-H, Li P, Huang Y-R, Li Z. Fertility outcome of patients with testicular tumor: before and after treatment. Asian J Androl. 2014;16(1):107\u201311.","journal-title":"Asian J Androl"},{"issue":"12","key":"545_CR60","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1200\/JCO.2010.33.7808","volume":"29","author":"W Hsiao","year":"2011","unstructured":"Hsiao W, Stahl PJ, Osterberg EC, Nejat E, Palermo GD, Rosenwaks Z, et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol. 2011;29(12):1607\u201311.","journal-title":"J Clin Oncol"},{"issue":"19","key":"545_CR61","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1056\/NEJMoa1301675","volume":"369","author":"CL Williams","year":"2013","unstructured":"Williams CL, Bunch KJ, Stiller CA, Murphy MFG, Botting BJ, Wallace WH, et al. Cancer risk among children born after assisted conception. N Engl J Med. 2013;369(19):1819\u201327.","journal-title":"N Engl J Med"},{"issue":"4","key":"545_CR62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/s-0034-1375178","volume":"32","author":"M Polat","year":"2014","unstructured":"Polat M, Bozdag G, Yarali H. Best protocol for controlled ovarian hyperstimulation in assisted reproductive technologies: fact or opinion? Semin Reprod Med. 2014;32(4):262\u201371.","journal-title":"Semin Reprod Med"},{"issue":"6","key":"545_CR63","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ctrv.2010.02.019","volume":"36","author":"A Balduzzi","year":"2010","unstructured":"Balduzzi A, Leonardi MC, Cardillo A, Orecchia R, Dellapasqua S, Iorfida M, et al. Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treat Rev. 2010;36(6):443\u201350.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"545_CR64","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.fertnstert.2013.03.029","volume":"99","author":"H Cakmak","year":"2013","unstructured":"Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013;99(6):1476\u201384.","journal-title":"Fertil Steril"},{"issue":"4","key":"545_CR65","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.fertnstert.2008.08.011","volume":"92","author":"M Wolff Von","year":"2009","unstructured":"Von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009;92(4):1360\u20135.","journal-title":"Fertil Steril"},{"issue":"2","key":"545_CR66","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejogrb.2009.12.023","volume":"149","author":"N Michaan","year":"2010","unstructured":"Michaan N, Ben-David G, Ben-Yosef D, Almog B, Many A, Pauzner D, et al. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. Eur J Obstet Gynecol Reprod Biol. 2010;149(2):175\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"545_CR67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10815-010-9429-0","volume":"27","author":"GM Bedoschi","year":"2010","unstructured":"Bedoschi GM, de Albuquerque FO, Ferriani RA, Navarro PA. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet. 2010;27(8):491\u20134.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"545_CR68","doi-asserted-by":"publisher","first-page":"2125.e9","DOI":"10.1016\/j.fertnstert.2011.01.030","volume":"95","author":"M S\u00f6nmezer","year":"2011","unstructured":"S\u00f6nmezer M, T\u00fcrk\u00e7\u00fco\u011flu I, Co\u015fkun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011;95(6):2125.e9\u201311.","journal-title":"Fertil Steril"},{"issue":"1","key":"545_CR69","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.fertnstert.2010.06.064","volume":"95","author":"E Maman","year":"2011","unstructured":"Maman E, Meirow D, Brengauz M, Raanani H, Dor J, Hourvitz A. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. Fertil Steril. 2011;95(1):64\u20137.","journal-title":"Fertil Steril"},{"issue":"1","key":"545_CR70","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.fertnstert.2011.04.079","volume":"96","author":"SR Nayak","year":"2011","unstructured":"Nayak SR, Wakim AN. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. Fertil Steril. 2011;96(1):e51\u20134.","journal-title":"Fertil Steril"},{"issue":"6","key":"545_CR71","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.fertnstert.2013.07.1992","volume":"100","author":"H Cakmak","year":"2013","unstructured":"Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100(6):1673\u201380.","journal-title":"Fertil Steril"},{"issue":"4","key":"545_CR72","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00404-013-2794-z","volume":"288","author":"NK Buendgen","year":"2013","unstructured":"Buendgen NK, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G. Initiation of ovarian stimulation independent of the menstrual cycle: a case\u2013control study. Arch Gynecol Obstet. 2013;288(4):901\u20134.","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"545_CR73","first-page":"830","volume":"64","author":"U Keskin","year":"2014","unstructured":"Keskin U, Ercan CM, Yilmaz A, Babacan A, Korkmaz C, Duru NK, et al. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature. J Pak Med Assoc. 2014;64(7):830\u20132.","journal-title":"J Pak Med Assoc"},{"key":"545_CR74","first-page":"CD008046","volume":"10","author":"MAFM Youssef","year":"2014","unstructured":"Youssef MAFM, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev. 2014;10:CD008046.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"545_CR75","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","volume":"102","author":"D Meirow","year":"2014","unstructured":"Meirow D, Raanani H, Maman E, Paluch-Shimon S, Shapira M, Cohen Y, et al. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Fertil Steril. 2014;102(2):488\u201395.","journal-title":"Fertil Steril"},{"issue":"11","key":"545_CR76","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3109\/09513590.2013.819083","volume":"29","author":"A Revelli","year":"2013","unstructured":"Revelli A, Porcu E, Levi Setti PE, Delle Piane L, Merlo DF, Anserini P. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer? Gynecol Endocrinol. 2013;29(11):993\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"545_CR77","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1210\/jc.2006-0962","volume":"91","author":"K Oktay","year":"2006","unstructured":"Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91(10):3885\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"545_CR78","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","volume":"33","author":"K Oktay","year":"2015","unstructured":"Oktay K, Turan V, Bedoschi G, Pacheco FS, Moy F. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. J Clin Oncol. 2015;33(22):2424\u20139.","journal-title":"J Clin Oncol"},{"issue":"16","key":"545_CR79","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","volume":"26","author":"AA Azim","year":"2008","unstructured":"Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26(16):2630\u20135.","journal-title":"J Clin Oncol"},{"key":"545_CR80","doi-asserted-by":"publisher","first-page":"abstract P5-15-","DOI":"10.1158\/1538-7445.SABCS14-P5-15-02","volume":"75","author":"K Oktay","year":"2015","unstructured":"Oktay K, Kim J, Bedoschi G, Turan V. Safety of letrozole-gonadotropin controlled ovarian stimulation protocol in women with breast cancer undergoing fertility preservation before or after tumor resection via embryo or oocyte cryopreservation: A prospective cohort study. Cancer Res. 2015;75:abstract P5-15-02.","journal-title":"Cancer Res"},{"issue":"6","key":"545_CR81","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.fertnstert.2013.08.030","volume":"100","author":"V Turan","year":"2013","unstructured":"Turan V, Bedoschi G, Moy F, Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril. 2013;100(6):1681\u20135.e1.","journal-title":"Fertil Steril"},{"issue":"1","key":"545_CR82","doi-asserted-by":"publisher","first-page":"228.e19","DOI":"10.1016\/j.fertnstert.2007.02.028","volume":"89","author":"K Oktay","year":"2008","unstructured":"Oktay K, Demirtas E, Son W-Y, Lostritto K, Chian R-C, Tan SL. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil Steril. 2008;89(1):228.e19\u201322.","journal-title":"Fertil Steril"},{"issue":"6","key":"545_CR83","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1055\/s-0029-1241055","volume":"27","author":"Y-X Cao","year":"2009","unstructured":"Cao Y-X, Chian R-C. Fertility preservation with immature and in vitro matured oocytes. Semin Reprod Med. 2009;27(6):456\u201364.","journal-title":"Semin Reprod Med"},{"issue":"2","key":"545_CR84","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/humrep\/det420","volume":"29","author":"EB Prasath","year":"2014","unstructured":"Prasath EB, Chan MLH, Wong WHW, Lim CJW, Tharmalingam MD, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod. 2014;29(2):276\u20138.","journal-title":"Hum Reprod"},{"issue":"12","key":"545_CR85","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.ejca.2015.05.007","volume":"51","author":"O Goldrat","year":"2015","unstructured":"Goldrat O, Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard O, et al. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. Eur J Cancer. 2015;51(12):1490\u20136.","journal-title":"Eur J Cancer"},{"issue":"6","key":"545_CR86","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/humupd\/dmm028","volume":"13","author":"DA Gook","year":"2007","unstructured":"Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update. 2007;13(6):591\u2013605.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"545_CR87","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.fertnstert.2009.10.029","volume":"94","author":"A Borini","year":"2010","unstructured":"Borini A, Levi Setti PE, Anserini P, De Luca R, De Santis L, Porcu E, et al. Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome. Fertil Steril. 2010;94(5):1662\u20138.","journal-title":"Fertil Steril"},{"issue":"6","key":"545_CR88","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.fertnstert.2009.12.065","volume":"94","author":"GD Smith","year":"2010","unstructured":"Smith GD, Serafini PC, Fioravanti J, Yadid I, Coslovsky M, Hassun P, et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril. 2010;94(6):2088\u201395.","journal-title":"Fertil Steril"},{"key":"545_CR89","first-page":"CD010047","volume":"9","author":"D Glujovsky","year":"2014","unstructured":"Glujovsky D, Riestra B, Sueldo C, Fiszbajn G, Repping S, Nodar F, et al. Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database Syst Rev. 2014;9:CD010047.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"545_CR90","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/humrep\/det242","volume":"28","author":"M Sol\u00e9","year":"2013","unstructured":"Sol\u00e9 M, Santal\u00f3 J, Boada M, Clua E, Rodr\u00edguez I, Mart\u00ednez F, et al. How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes. Hum Reprod. 2013;28(8):2087\u201392.","journal-title":"Hum Reprod"},{"issue":"2","key":"545_CR91","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.fertnstert.2013.04.023","volume":"100","author":"AP Cil","year":"2013","unstructured":"Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril. 2013;100(2):492\u20139.e3.","journal-title":"Fertil Steril"},{"issue":"1","key":"545_CR92","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.fertnstert.2014.03.052","volume":"102","author":"PE Levi Setti","year":"2014","unstructured":"Levi Setti PE, Porcu E, Patrizio P, Vigiliano V, De Luca R, D\u2019 Aloja P, et al. Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007\u20132011. Fertil Steril. 2014;102(1):90\u20135.e2.","journal-title":"Fertil Steril"},{"key":"545_CR93","unstructured":"Clinic Summary Report. \n                    https:\/\/www.sartcorsonline.com\/rptCSR_PublicMultYear.aspx?ClinicPKID=0\n                    \n                  . Accessed 22 Dec 2015."},{"issue":"5","key":"545_CR94","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.fertnstert.2012.01.127","volume":"97","author":"V Bianchi","year":"2012","unstructured":"Bianchi V, Lappi M, Bonu MA, Borini A. Oocyte slow freezing using a 0.2-0.3\u00a0M sucrose concentration protocol: is it really the time to trash the cryopreservation machine? Fertil Steril. 2012;97(5):1101\u20137.","journal-title":"Fertil Steril"},{"issue":"6","key":"545_CR95","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/humrep\/des088","volume":"27","author":"L Rienzi","year":"2012","unstructured":"Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Vajta G, et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod. 2012;27(6):1606\u201312.","journal-title":"Hum Reprod"},{"issue":"3","key":"545_CR96","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.fertnstert.2008.10.007","volume":"93","author":"RB Quintero","year":"2010","unstructured":"Quintero RB, Helmer A, Huang JQ, Westphal LM. Ovarian stimulation for fertility preservation in patients with cancer. Fertil Steril. 2010;93(3):865\u20138.","journal-title":"Fertil Steril"},{"issue":"4","key":"545_CR97","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","volume":"97","author":"J Domingo","year":"2012","unstructured":"Domingo J, Guill\u00e9n V, Ayll\u00f3n Y, Mart\u00ednez M, Mu\u00f1oz E, Pellicer A, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril. 2012;97(4):930\u20134.","journal-title":"Fertil Steril"},{"issue":"2","key":"545_CR98","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","volume":"28","author":"K Oktay","year":"2010","unstructured":"Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks. J Clin Oncol. 2010;28(2):240\u20134.","journal-title":"J Clin Oncol"},{"issue":"6","key":"545_CR99","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.fertnstert.2008.12.052","volume":"93","author":"T Pal","year":"2010","unstructured":"Pal T, Keefe D, Sun P, Narod SA. Hereditary Breast Cancer Clinical Study Group. Fertility in women with BRCA mutations: a case\u2013control study. Fertil Steril. 2010;93(6):1805\u20138.","journal-title":"Fertil Steril"},{"issue":"6","key":"545_CR100","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.rbmo.2014.02.010","volume":"28","author":"M Alvarez","year":"2014","unstructured":"Alvarez M, Sol\u00e9 M, Devesa M, F\u00e1bregas R, Boada M, Tur R, et al. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online. 2014;28(6):663\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"545_CR101","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.rbmo.2014.09.002","volume":"29","author":"M Martinez","year":"2014","unstructured":"Martinez M, Rabadan S, Domingo J, Cobo A, Pellicer A, Garcia-Velasco JA. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. Reprod Biomed Online. 2014;29(6):722\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"545_CR102","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.fertnstert.2008.04.019","volume":"91","author":"SS Kim","year":"2009","unstructured":"Kim SS, Lee WS, Chung MK, Lee HC, Lee HH, Hill D. Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients. Fertil Steril. 2009;91(6):2349\u201354.","journal-title":"Fertil Steril"},{"issue":"2","key":"545_CR103","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.rbmo.2012.03.014","volume":"25","author":"CY Andersen","year":"2012","unstructured":"Andersen CY, Silber SJ, Bergholdt SH, Berghold SH, Jorgensen JS, Ernst E. Long-term duration of function of ovarian tissue transplants: case reports. Reprod Biomed Online. 2012;25(2):128\u201332.","journal-title":"Reprod Biomed Online"},{"issue":"9967","key":"545_CR104","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0140-6736(15)60198-2","volume":"385","author":"J Donnez","year":"2015","unstructured":"Donnez J, Dolmans M-M, Pellicer A, Diaz-Garcia C, Ernst E, Macklon KT, et al. Fertility preservation for age-related fertility decline. Lancet. 2015;385(9967):506\u20137.","journal-title":"Lancet"},{"issue":"9981","key":"545_CR105","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(15)60960-6","volume":"385","author":"CY Andersen","year":"2015","unstructured":"Andersen CY. Success and challenges in fertility preservation after ovarian tissue grafting. Lancet. 2015;385(9981):1947\u20138.","journal-title":"Lancet"},{"issue":"6","key":"545_CR106","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.fertnstert.2013.03.030","volume":"99","author":"J Donnez","year":"2013","unstructured":"Donnez J, Dolmans M-M, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99(6):1503\u201313.","journal-title":"Fertil Steril"},{"issue":"8","key":"545_CR107","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.bpobgyn.2014.09.003","volume":"28","author":"J Donnez","year":"2014","unstructured":"Donnez J, Dolmans M-M. Transplantation of ovarian tissue. Best Pract Res Clin Obstet Gynaecol. 2014;28(8):1188\u201397.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"11","key":"545_CR108","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s10815-014-0331-z","volume":"31","author":"KT Macklon","year":"2014","unstructured":"Macklon KT, Jensen AK, Loft A, Ernst E, Andersen CY. Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation. J Assist Reprod Genet. 2014;31(11):1557\u201364.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"545_CR109","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.fertnstert.2014.10.045","volume":"103","author":"R Dittrich","year":"2015","unstructured":"Dittrich R, Hackl J, Lotz L, Hoffmann I, Beckmann MW. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103(2):462\u20138.","journal-title":"Fertil Steril"},{"key":"545_CR110","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/978-1-4939-0659-8_21","volume":"1154","author":"D Meirow","year":"2014","unstructured":"Meirow D, Ra\u2019anani H, Biderman H. Ovarian tissue cryopreservation and transplantation: a realistic, effective technology for fertility preservation. Methods Mol Biol. 2014;1154:455\u201373.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"545_CR111","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.reprotox.2010.07.003","volume":"30","author":"H Bar-Joseph","year":"2010","unstructured":"Bar-Joseph H, Ben-Aharon I, Rizel S, Stemmer SM, Tzabari M, Shalgi R. Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes. Reprod Toxicol. 2010;30(4):566\u201372.","journal-title":"Reprod Toxicol"},{"issue":"3","key":"545_CR112","doi-asserted-by":"publisher","first-page":"e17877","DOI":"10.1371\/journal.pone.0017877","volume":"6","author":"LL Kujjo","year":"2011","unstructured":"Kujjo LL, Chang EA, Pereira RJG, Dhar S, Marrero-Rosado B, Sengupta S, et al. Chemotherapy-induced late transgenerational effects in mice. PLoS One. 2011;6(3):e17877.","journal-title":"PLoS One"},{"issue":"22","key":"545_CR113","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1182\/blood-2012-01-403022","volume":"120","author":"T Greve","year":"2012","unstructured":"Greve T, Clasen-Linde E, Andersen MT, Andersen MK, S\u00f8rensen SD, Rosendahl M, et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120(22):4311\u20136.","journal-title":"Blood"},{"issue":"4","key":"545_CR114","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1210\/jcem.87.4.8367","volume":"87","author":"K Oktay","year":"2002","unstructured":"Oktay K. Evidence for limiting ovarian tissue harvesting for the purpose of transplantation to women younger than 40\u00a0years of age. J Clin Endocrinol Metab. 2002;87(4):1907\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"545_CR115","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.fertnstert.2009.11.032","volume":"94","author":"M Rosendahl","year":"2010","unstructured":"Rosendahl M, Andersen MT, Ralfki\u00e6r E, Kjeldsen L, Andersen MK, Andersen CY. Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. Fertil Steril. 2010;94(6):2186\u201390.","journal-title":"Fertil Steril"},{"issue":"1","key":"545_CR116","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10815-012-9912-x","volume":"30","author":"M Rosendahl","year":"2013","unstructured":"Rosendahl M, Greve T, Andersen CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet. 2013;30(1):11\u201324.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"545_CR117","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/fon.13.183","volume":"10","author":"SD S\u00f8rensen","year":"2014","unstructured":"S\u00f8rensen SD, Greve T, Wielenga VT, Wallace WHB, Andersen CY. Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing\u2019s sarcoma. Future Oncol. 2014;10(2):277\u201383.","journal-title":"Future Oncol"},{"issue":"5","key":"545_CR118","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/humupd\/dmt020","volume":"19","author":"L Bastings","year":"2013","unstructured":"Bastings L, Beerendonk CCM, Westphal JR, Massuger LF. a. G, Kaal SEJ, van Leeuwen FE, et al. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update. 2013;19(5):483\u2013506.","journal-title":"Hum Reprod Update"},{"issue":"2\u20133","key":"545_CR119","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0093-691X(03)00226-7","volume":"61","author":"CM Lucci","year":"2004","unstructured":"Lucci CM, Kacinskis MA, Rumpf R, B\u00e1o SN. Effects of lowered temperatures and media on short-term preservation of zebu (Bos indicus) preantral ovarian follicles. Theriogenology. 2004;61(2\u20133):461\u201372.","journal-title":"Theriogenology"},{"issue":"12","key":"545_CR120","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1093\/humrep\/deg500","volume":"18","author":"KLT Schmidt","year":"2003","unstructured":"Schmidt KLT, Ernst E, Byskov AG, Nyboe Andersen A, Yding AC. Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. Hum Reprod. 2003;18(12):2654\u20139.","journal-title":"Hum Reprod"},{"issue":"2","key":"545_CR121","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.rbmo.2010.10.015","volume":"22","author":"M Rosendahl","year":"2011","unstructured":"Rosendahl M, Schmidt KT, Ernst E, Rasmussen PE, Loft A, Byskov AG, et al. Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online. 2011;22(2):162\u201371.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"545_CR122","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.fertnstert.2011.11.047","volume":"97","author":"R Dittrich","year":"2012","unstructured":"Dittrich R, Lotz L, Keck G, Hoffmann I, Mueller A, Beckmann MW, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012;97(2):387\u201390.","journal-title":"Fertil Steril"},{"issue":"1","key":"545_CR123","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/GCO.0000000000000138","volume":"27","author":"M Lambertini","year":"2015","unstructured":"Lambertini M, Ginsburg ES, Partridge AH. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015;27(1):98\u2013107.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"545_CR124","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","volume":"91","author":"A Badawy","year":"2009","unstructured":"Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril. 2009;91(3):694\u20137.","journal-title":"Fertil Steril"},{"issue":"3","key":"545_CR125","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10549-009-0313-5","volume":"117","author":"A Sverrisdottir","year":"2009","unstructured":"Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat. 2009;117(3):561\u20137.","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"545_CR126","doi-asserted-by":"crossref","first-page":"abstract 590","DOI":"10.1200\/jco.2010.28.15_suppl.590","volume":"28","author":"RC Leonard","year":"2010","unstructured":"Leonard RC, Adamson D, Anderson R, Ballinger R, Bertelli G, Coleman RE, et al. The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer. J Clin Oncol. 2010;28(15):abstract 590.","journal-title":"J Clin Oncol"},{"issue":"3","key":"545_CR127","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2011.991","volume":"306","author":"L Mastro Del","year":"2011","unstructured":"Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA. 2011;306(3):269\u201376.","journal-title":"JAMA"},{"issue":"17","key":"545_CR128","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","volume":"29","author":"B Gerber","year":"2011","unstructured":"Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011;29(17):2334\u201341.","journal-title":"J Clin Oncol"},{"issue":"5","key":"545_CR129","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1200\/JCO.2011.34.6890","volume":"30","author":"PN Munster","year":"2012","unstructured":"Munster PN, Moore AP, Ismail-Khan R, Cox CE, Lacevic M, Gross-King M, et al. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol. 2012;30(5):533\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"545_CR130","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/AOG.0b013e31827374e2","volume":"121","author":"EA Elgindy","year":"2013","unstructured":"Elgindy EA, El-Haieg DO, Khorshid OM, Ismail EI, Abdelgawad M, Sallam HN, et al. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial. Obstet Gynecol. 2013;121(1):78\u201386.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"545_CR131","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12032-013-0667-8","volume":"30","author":"G Song","year":"2013","unstructured":"Song G, Gao H, Yuan Z. Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial. Med Oncol. 2013;30(3):667.","journal-title":"Med Oncol"},{"issue":"1","key":"545_CR132","first-page":"59","volume":"35","author":"M Karimi-Zarchi","year":"2014","unstructured":"Karimi-Zarchi M, Forat-Yazdi M, Vafaeenasab MR, Nakhaie-Moghadam M, Miratashi-Yazdi A, Teimoori S, et al. Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide. Eur J Gynaecol Oncol. 2014;35(1):59\u201361.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"10","key":"545_CR133","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1413204","volume":"372","author":"HCF Moore","year":"2015","unstructured":"Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372(10):923\u201332.","journal-title":"N Engl J Med"},{"issue":"10","key":"545_CR134","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/annonc\/mdq066","volume":"21","author":"K Behringer","year":"2010","unstructured":"Behringer K, Wildt L, Mueller H, Mattle V, Ganitis P, van den Hoonaard B, et al. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol. 2010;21(10):2052\u201360.","journal-title":"Ann Oncol"},{"issue":"7","key":"545_CR135","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1200\/JCO.2012.42.8185","volume":"31","author":"I Demeestere","year":"2013","unstructured":"Demeestere I, Brice P, Peccatori FA, Kentos A, Gaillard I, Zachee P, et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol. 2013;31(7):903\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"545_CR136","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1743-7563.2007.00089.x","volume":"3","author":"MM Gilani","year":"2007","unstructured":"Gilani MM, Hasanzadeh M, Ghaemmaghami F, Ramazanzadeh F. Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy. Asia Pac J Clin Oncol. 2007;3(2):79\u201383.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"5","key":"545_CR137","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.breast.2014.05.024","volume":"23","author":"N Tomasi-Cont","year":"2014","unstructured":"Tomasi-Cont N, Lambertini M, Hulsbosch S, Peccatori AF, Amant F. Strategies for fertility preservation in young early breast cancer patients. Breast. 2014;23(5):503\u201310.","journal-title":"Breast"},{"issue":"3","key":"545_CR138","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/jwh.2008.0857","volume":"18","author":"MEB Clowse","year":"2009","unstructured":"Clowse MEB, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health 2002. 2009;18(3):311\u20139.","journal-title":"J Womens Health 2002"},{"issue":"3","key":"545_CR139","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10549-010-0996-7","volume":"122","author":"I Ben-Aharon","year":"2010","unstructured":"Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2010;122(3):803\u201311.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"545_CR140","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/GRF.0b013e3181f96cb1","volume":"53","author":"SS Kim","year":"2010","unstructured":"Kim SS, Lee JR, Jee BC, Suh CS, Kim SH, Ting A, et al. Use of hormonal protection for chemotherapy-induced gonadotoxicity. Clin Obstet Gynecol. 2010;53(4):740\u201352.","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"545_CR141","doi-asserted-by":"publisher","first-page":"e1\u20134","DOI":"10.1016\/j.fertnstert.2010.11.017","volume":"95","author":"MA Bedaiwy","year":"2011","unstructured":"Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):e1\u20134\u201314.","journal-title":"Fertil Steril"},{"key":"545_CR142","first-page":"CD008018","volume":"11","author":"H Chen","year":"2011","unstructured":"Chen H, Li J, Cui T, Hu L. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. 2011;11:CD008018.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"545_CR143","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.breast.2012.12.008","volume":"22","author":"B Yang","year":"2013","unstructured":"Yang B, Shi W, Yang J, Liu H, Zhao H, Li X, et al. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials. Breast. 2013;22(2):150\u20137.","journal-title":"Breast"},{"issue":"6","key":"545_CR144","doi-asserted-by":"publisher","first-page":"e66360","DOI":"10.1371\/journal.pone.0066360","volume":"8","author":"C Wang","year":"2013","unstructured":"Wang C, Chen M, Fu F, Huang M. Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis. PLoS One. 2013;8(6):e66360.","journal-title":"PLoS One"},{"issue":"5","key":"545_CR145","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ctrv.2013.12.001","volume":"40","author":"L Mastro Del","year":"2014","unstructured":"Del Mastro L, Ceppi M, Poggio F, Bighin C, Peccatori F, Demeestere I, et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev. 2014;40(5):675\u201383.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"545_CR146","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.fertnstert.2014.06.003","volume":"102","author":"WS Vitek","year":"2014","unstructured":"Vitek WS, Shayne M, Hoeger K, Han Y, Messing S, Fung C. Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis. Fertil Steril. 2014;102(3):808\u201315. e1.","journal-title":"Fertil Steril"},{"issue":"4","key":"545_CR147","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3892\/ijo.2014.2296","volume":"44","author":"X Sun","year":"2014","unstructured":"Sun X, Dongol S, Jiang J, Kong B. Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis. Int J Oncol. 2014;44(4):1335\u201340.","journal-title":"Int J Oncol"},{"issue":"1","key":"545_CR148","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/AOG.0000000000000905","volume":"126","author":"E Elgindy","year":"2015","unstructured":"Elgindy E, Sibai H, Abdelghani A, Mostafa M. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015;126(1):187\u201395.","journal-title":"Obstet Gynecol"},{"key":"545_CR149","doi-asserted-by":"crossref","unstructured":"Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA Jr, Ugolini D, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol 2015; 26(12):2408-19.","DOI":"10.1093\/annonc\/mdv374"},{"key":"545_CR150","doi-asserted-by":"crossref","unstructured":"Lambertini M, Boni L, Michelotti A, Gamucci T, Scotto T, Gori S, et al. Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival. A randomized clinical trial. JAMA. 2015;314(24):2632-40.","DOI":"10.1001\/jama.2015.17291"},{"issue":"8","key":"545_CR151","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","volume":"26","author":"AS Coates","year":"2015","unstructured":"Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, et al. Tailoring therapies - improving the management of early breast cancer: St GallenInternational Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol. 2015;26(8):1533\u201346.","journal-title":"Ann Oncol"},{"key":"545_CR152","unstructured":"National Comprehensive Cancer Network (NCCN) Guidelines. \n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf\n                    \n                  . Accessed 22 Dec 2015."},{"key":"545_CR153","unstructured":"University of York. Centre for Reviews and Dissemination. Luteinizing hormone-releasing hormone (LHRH) analogs as a strategy to protect ovarian function and fertility in premenopausal breast cancer patients undergoing chemotherapy: an individual patient data meta-analysis of randomized trials (The MOMMY study). \n                    http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42014015638#.VLglxydetKp\n                    \n                  . Accessed 22 Dec 2015."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-015-0545-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0545-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T12:45:32Z","timestamp":1583153132000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-015-0545-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,4]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["545"],"URL":"https:\/\/doi.org\/10.1186\/s12916-015-0545-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,4]]},"assertion":[{"value":"15 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}